We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
351
Agios Pharmaceuticals
AGIO
$2.16B
$854K 0.05%
30,144
-8,380
-22% -$209K
EDIT icon
352
Editas Medicine
EDIT
$399M
$852K 0.05%
103,503
-22,239
-18% -$194K
CL icon
353
Colgate-Palmolive
CL
$72.6B
$851K 0.05%
11,045
-48
-0.4% -$3.71K
AON icon
354
Aon
AON
$77.3B
$846K 0.05%
2,450
-53
-2% -$17.2K
RCKT icon
355
Rocket Pharmaceuticals
RCKT
$348M
$845K 0.05%
42,502
-13,014
-23% -$263K
RGLD icon
356
Royal Gold
RGLD
$17.1B
$843K 0.05%
7,347
-208
-3% -$26.8K
Z icon
357
Zillow
Z
$7.04B
$843K 0.05%
16,776
+662
+4% +$30.4K
VMC icon
358
Vulcan Materials
VMC
$36.3B
$840K 0.05%
3,724
+183
+5% +$35.1K
JAZZ icon
359
Jazz Pharmaceuticals
JAZZ
$15.9B
$838K 0.04%
6,757
+282
+4% +$37.9K
OPEN icon
360
Opendoor
OPEN
$3.69B
$836K 0.04%
214,930
-15,054
-7% -$32.7K
ACLX
361
DELISTED
Arcellx
ACLX
$833K 0.04%
26,345
+56
+0.2% +$2.14K
BHVN icon
362
Biohaven
BHVN
$2.16B
$833K 0.04%
34,819
-31,189
-47% -$537K
BOX icon
363
Box
BOX
$4.02B
$829K 0.04%
28,220
+2,353
+9% +$65.2K
BBD icon
364
Banco Bradesco
BBD
$38.1B
$827K 0.04%
239,149
+3,027
+1% +$9.35K
VTRS icon
365
Viatris
VTRS
$20.1B
$827K 0.04%
82,868
+6,806
+9% +$65K
TEL icon
366
TE Connectivity
TEL
$58.8B
$824K 0.04%
5,880
+1,541
+36% +$195K
ITW icon
367
Illinois Tool Works
ITW
$81.4B
$823K 0.04%
3,289
+252
+8% +$59K
ARCT icon
368
Arcturus Therapeutics
ARCT
$157M
$820K 0.04%
28,608
-887
-3% -$24.1K
HP icon
369
Helmerich & Payne
HP
$3.53B
$820K 0.04%
23,132
+1,242
+6% +$42.4K
VERV
370
DELISTED
Verve Therapeutics
VERV
$818K 0.04%
43,602
-5,125
-11% -$85.4K
FATE icon
371
Fate Therapeutics
FATE
$281M
$815K 0.04%
171,261
-83,728
-33% -$462K
ICPT
372
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$815K 0.04%
73,688
+25,860
+54% +$360K
PPL
373
PPL Corp
PPL
$27.3B
$812K 0.04%
30,681
-2,768
-8% -$76.3K
VAL icon
374
Valaris
VAL
$5.51B
$811K 0.04%
12,888
+302
+2% +$18.2K
NOV icon
375
NOV
NOV
$7.45B
$810K 0.04%
50,476
+7,117
+16% +$116K
13 14
15
16 17

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.